<?xml version="1.0" encoding="UTF-8"?>
<p>Serum HCV RNA testing 12 weeks after the EoT was performed in 144/174 (82.8%) patients. Finally, 139 patients achieved SVR12. The SVR12 rate in an intention-to-treat analysis (ITT) was 79.9% (139/174), while for those with an SVR12 test available the response rate reached 96.5% (139/144) (
 <xref ref-type="fig" rid="F1">Fig. 1</xref>).
</p>
